Taiho Oncology, Inc.
Phil Paek has extensive work experience in the pharmaceutical industry, particularly in the field of oncology. Phil began their career in 1998 at Roche, where they held multiple roles, including Senior Therapeutic Specialist in various therapeutic areas. Phil then served as a Strategic Partnerships Manager and Regional Sales Manager before becoming the National Sales Manager for Oncology. In 2012, Phil joined MediSystem Pharmacy as a New Business Development professional. Phil then moved on to InterMune, where they worked as an Area Business Manager from 2013 to 2015. Phil then joined Novartis-Oncology as a Senior Specialty Sales Consultant. In 2016, they joined Bayer Pharmaceuticals-Oncology as a Key Account Manager, a role they held until 2017. Currently, Phil works as a Clinical Science Associate at Taiho Oncology Inc, utilizing their experience and knowledge in the field of oncology.
Phil Paek attended McMaster University. No information regarding the start year, end year, degree name, or field of study was provided.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com